Back to MW MARSHALL WACE, LLPENENGN
ENENGN2 quarters
Position history for MWMARSHALL WACE, LLP's holdings in ENGENE THERAPEUTICS INC COM
No. Marshall Wace exited its ENGN (Engene Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 343,928 shares worth $2.3M. Marshall Wace first reported ENGN in Q1 2026 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$2.3M
Total Shares Change
-343,928
Quarter-by-Quarter History
Other major holders of ENGN: AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC